Cargando…

Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients

BACKGROUND: Emerging evidence suggests that DNA methylation can be affected by physical activities and is associated with cardiac fibrosis. This translational research examined the implications of DNA methylation associated with the high-intensity interval training (HIIT) effects on cardiac fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chih-Chin, Wang, Jong-Shyan, Shyu, Yu-Chiau, Fu, Tieh-Cheng, Juan, Yu-Hsiang, Yuan, Shin-Sheng, Wang, Chao-Hung, Yeh, Chi-Hsiao, Liao, Po-Cheng, Wu, Hsin-Yi, Hsu, Pang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999524/
https://www.ncbi.nlm.nih.gov/pubmed/36894992
http://dx.doi.org/10.1186/s12967-023-04032-7
_version_ 1784903677249585152
author Hsu, Chih-Chin
Wang, Jong-Shyan
Shyu, Yu-Chiau
Fu, Tieh-Cheng
Juan, Yu-Hsiang
Yuan, Shin-Sheng
Wang, Chao-Hung
Yeh, Chi-Hsiao
Liao, Po-Cheng
Wu, Hsin-Yi
Hsu, Pang-Hung
author_facet Hsu, Chih-Chin
Wang, Jong-Shyan
Shyu, Yu-Chiau
Fu, Tieh-Cheng
Juan, Yu-Hsiang
Yuan, Shin-Sheng
Wang, Chao-Hung
Yeh, Chi-Hsiao
Liao, Po-Cheng
Wu, Hsin-Yi
Hsu, Pang-Hung
author_sort Hsu, Chih-Chin
collection PubMed
description BACKGROUND: Emerging evidence suggests that DNA methylation can be affected by physical activities and is associated with cardiac fibrosis. This translational research examined the implications of DNA methylation associated with the high-intensity interval training (HIIT) effects on cardiac fibrosis in patients with heart failure (HF). METHODS: Twelve HF patients were included and received cardiovascular magnetic resonance imaging with late gadolinium enhancement for cardiac fibrosis severity and a cardiopulmonary exercise test for peak oxygen consumption ([Formula: see text] O(2peak)). Afterwards, they underwent 36 sessions of HIIT at alternating 80% and 40% of [Formula: see text] O(2peak) for 30 min per session in 3–4 months. Human serum from 11 participants, as a means to link cell biology to clinical presentations, was used to investigate the exercise effects on cardiac fibrosis. Primary human cardiac fibroblasts (HCFs) were incubated in patient serum, and analyses of cell behaviour, proteomics (n = 6) and DNA methylation profiling (n = 3) were performed. All measurements were conducted after completing HIIT. RESULTS: A significant increase (p = 0.009) in [Formula: see text] O(2peak) (pre- vs. post-HIIT = 19.0 ± 1.1 O(2) ml/kg/min vs. 21.8 ± 1.1 O(2) ml/kg/min) was observed after HIIT. The exercise strategy resulted in a significant decrease in left ventricle (LV) volume by 15% to 40% (p < 0.05) and a significant increase in LV ejection fraction by approximately 30% (p = 0.010). LV myocardial fibrosis significantly decreased from 30.9 ± 1.2% to 27.2 ± 0.8% (p = 0.013) and from 33.4 ± 1.6% to 30.1 ± 1.6% (p = 0.021) in the middle and apical LV myocardium after HIIT, respectively. The mean single-cell migration speed was significantly (p = 0.044) greater for HCFs treated with patient serum before (2.15 ± 0.17 μm/min) than after (1.11 ± 0.12 μm/min) HIIT. Forty-three of 1222 identified proteins were significantly involved in HIIT-induced altered HCF activities. There was significant (p = 0.044) hypermethylation of the acyl-CoA dehydrogenase very long chain (ACADVL) gene with a 4.474-fold increase after HIIT, which could activate downstream caspase-mediated actin disassembly and the cell death pathway. CONCLUSIONS: Human investigation has shown that HIIT is associated with reduced cardiac fibrosis in HF patients. Hypermethylation of ACADVL after HIIT may contribute to impeding HCF activities. This exercise-associated epigenetic reprogramming may contribute to reduce cardiac fibrosis and promote cardiorespiratory fitness in HF patients. Trial registration: NCT04038723. Registered 31 July 2019, https://clinicaltrials.gov/ct2/show/NCT04038723. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04032-7.
format Online
Article
Text
id pubmed-9999524
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99995242023-03-11 Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients Hsu, Chih-Chin Wang, Jong-Shyan Shyu, Yu-Chiau Fu, Tieh-Cheng Juan, Yu-Hsiang Yuan, Shin-Sheng Wang, Chao-Hung Yeh, Chi-Hsiao Liao, Po-Cheng Wu, Hsin-Yi Hsu, Pang-Hung J Transl Med Research BACKGROUND: Emerging evidence suggests that DNA methylation can be affected by physical activities and is associated with cardiac fibrosis. This translational research examined the implications of DNA methylation associated with the high-intensity interval training (HIIT) effects on cardiac fibrosis in patients with heart failure (HF). METHODS: Twelve HF patients were included and received cardiovascular magnetic resonance imaging with late gadolinium enhancement for cardiac fibrosis severity and a cardiopulmonary exercise test for peak oxygen consumption ([Formula: see text] O(2peak)). Afterwards, they underwent 36 sessions of HIIT at alternating 80% and 40% of [Formula: see text] O(2peak) for 30 min per session in 3–4 months. Human serum from 11 participants, as a means to link cell biology to clinical presentations, was used to investigate the exercise effects on cardiac fibrosis. Primary human cardiac fibroblasts (HCFs) were incubated in patient serum, and analyses of cell behaviour, proteomics (n = 6) and DNA methylation profiling (n = 3) were performed. All measurements were conducted after completing HIIT. RESULTS: A significant increase (p = 0.009) in [Formula: see text] O(2peak) (pre- vs. post-HIIT = 19.0 ± 1.1 O(2) ml/kg/min vs. 21.8 ± 1.1 O(2) ml/kg/min) was observed after HIIT. The exercise strategy resulted in a significant decrease in left ventricle (LV) volume by 15% to 40% (p < 0.05) and a significant increase in LV ejection fraction by approximately 30% (p = 0.010). LV myocardial fibrosis significantly decreased from 30.9 ± 1.2% to 27.2 ± 0.8% (p = 0.013) and from 33.4 ± 1.6% to 30.1 ± 1.6% (p = 0.021) in the middle and apical LV myocardium after HIIT, respectively. The mean single-cell migration speed was significantly (p = 0.044) greater for HCFs treated with patient serum before (2.15 ± 0.17 μm/min) than after (1.11 ± 0.12 μm/min) HIIT. Forty-three of 1222 identified proteins were significantly involved in HIIT-induced altered HCF activities. There was significant (p = 0.044) hypermethylation of the acyl-CoA dehydrogenase very long chain (ACADVL) gene with a 4.474-fold increase after HIIT, which could activate downstream caspase-mediated actin disassembly and the cell death pathway. CONCLUSIONS: Human investigation has shown that HIIT is associated with reduced cardiac fibrosis in HF patients. Hypermethylation of ACADVL after HIIT may contribute to impeding HCF activities. This exercise-associated epigenetic reprogramming may contribute to reduce cardiac fibrosis and promote cardiorespiratory fitness in HF patients. Trial registration: NCT04038723. Registered 31 July 2019, https://clinicaltrials.gov/ct2/show/NCT04038723. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04032-7. BioMed Central 2023-03-10 /pmc/articles/PMC9999524/ /pubmed/36894992 http://dx.doi.org/10.1186/s12967-023-04032-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hsu, Chih-Chin
Wang, Jong-Shyan
Shyu, Yu-Chiau
Fu, Tieh-Cheng
Juan, Yu-Hsiang
Yuan, Shin-Sheng
Wang, Chao-Hung
Yeh, Chi-Hsiao
Liao, Po-Cheng
Wu, Hsin-Yi
Hsu, Pang-Hung
Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title_full Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title_fullStr Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title_full_unstemmed Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title_short Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
title_sort hypermethylation of acadvl is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999524/
https://www.ncbi.nlm.nih.gov/pubmed/36894992
http://dx.doi.org/10.1186/s12967-023-04032-7
work_keys_str_mv AT hsuchihchin hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT wangjongshyan hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT shyuyuchiau hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT futiehcheng hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT juanyuhsiang hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT yuanshinsheng hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT wangchaohung hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT yehchihsiao hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT liaopocheng hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT wuhsinyi hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients
AT hsupanghung hypermethylationofacadvlisinvolvedinthehighintensityintervaltrainingassociatedreductionofcardiacfibrosisinheartfailurepatients